Profile
Michele Manto is currently a Venture Partner at Xgen Venture Sgr SpA since 2023.
Prior to this, he worked as the Chief Commercial Officer at Galapagos NV from 2020 to 2023.
He was also a Board Member at Nefarma from 2015 to 2017.
Mr. Manto received an MBA from INSEAD and an undergraduate degree from Politecnico di Milano.
Michele Manto active positions
| Companies | Position | Start |
|---|---|---|
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance XGEN Venture invests in companies located in Italy. The firm focuses on the life science sectors. It participates in early stage capital transactions. | Private Equity Investor | 01/01/2023 |
Former positions of Michele Manto
| Companies | Position | End |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Corporate Officer/Principal | 31/12/2023 |
Nefarma
Nefarma Miscellaneous Commercial ServicesCommercial Services Operates as a trade association of pharmaceutical manufacturers | Director/Board Member | 01/01/2017 |
Politecnico di Milano
Politecnico di Milano Other Consumer ServicesConsumer Services Functions as a College/University | Chief Tech/Sci/R&D Officer | - |
Training of Michele Manto
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Galapagos NV
Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
INSEAD
INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Politecnico di Milano
Politecnico di Milano Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nefarma
Nefarma Miscellaneous Commercial ServicesCommercial Services Operates as a trade association of pharmaceutical manufacturers | Commercial Services |
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance XGEN Venture invests in companies located in Italy. The firm focuses on the life science sectors. It participates in early stage capital transactions. | Finance |
- Stock Market
- Insiders
- Michele Manto
















